Robert A Anders Selected Research

Robert A Anders Research Topics

Disease

72	Neoplasms (Cancer) 12/2021 - 01/2006
14	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 05/2010
12	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 06/2012
12	Carcinogenesis 01/2021 - 03/2003
11	Melanoma (Melanoma, Malignant) 11/2021 - 03/2012
9	Adenocarcinoma 01/2021 - 04/2011
8	Inflammation (Inflammations) 01/2021 - 03/2004
8	Pancreatic Neoplasms (Pancreatic Cancer) 10/2020 - 04/2009
7	Fibrosis (Cirrhosis) 01/2022 - 03/2003
5	Cholangiocarcinoma 01/2022 - 09/2012
5	Liver Diseases (Liver Disease) 11/2021 - 09/2011
4	Neoplasm Metastasis (Metastasis) 01/2019 - 04/2011
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 06/2012
4	Liver Neoplasms (Liver Cancer) 01/2016 - 09/2012
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 03/2004
3	Infections 01/2018 - 01/2014
3	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 06/2012
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2016 - 01/2013
3	Hepatomegaly 06/2012 - 07/2005
2	End Stage Liver Disease 01/2022 - 01/2018
2	Weight Loss (Weight Reduction) 01/2022 - 01/2022
2	Myocarditis (Carditis) 10/2021 - 11/2016
2	Weight Gain 09/2020 - 10/2018
2	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 05/2012
2	Microsatellite Instability 12/2019 - 10/2019
2	Merkel Cell Carcinoma 10/2018 - 07/2013
2	Carcinoma (Carcinomatosis) 09/2017 - 06/2015
2	Turcot syndrome 01/2017 - 06/2015
2	Cholestasis 12/2016 - 05/2014
2	Circulating Neoplastic Cells 12/2016 - 10/2016
2	Hypoxia (Hypoxemia) 10/2015 - 04/2009
2	Body Weight (Weight, Body) 06/2015 - 06/2012
1	Hemoglobin SC Disease (Disease, Hemoglobin SC) 01/2022
1	Autoimmune Hepatitis 01/2022
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022
1	Neoplasm Micrometastasis 01/2022
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2021
1	Thrombocytopenia (Thrombopenia) 12/2021
1	Exanthema (Rash) 12/2021

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2008
14	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2013
14	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2016
8	LigandsIBA 12/2021 - 03/2004
7	CytokinesIBA 01/2018 - 03/2005
6	NivolumabIBA 01/2022 - 01/2013
6	B7-H1 AntigenIBA 12/2021 - 01/2017
6	AntigensIBA 01/2021 - 03/2005
6	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021 - 01/2015
6	VaccinesIBA 01/2021 - 01/2015
6	ParaffinIBA 01/2020 - 01/2013
6	Transcription Factors (Transcription Factor)IBA 07/2017 - 04/2009
6	AntibodiesIBA 01/2017 - 04/2011
5	Formaldehyde (Formol)FDA Link 01/2020 - 01/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2009
4	pembrolizumabIBA 01/2020 - 06/2015
4	EnzymesIBA 01/2019 - 04/2009
3	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 03/2012
3	IpilimumabIBA 11/2021 - 11/2016
3	Tumor Biomarkers (Tumor Markers)IBA 12/2019 - 10/2016
3	Annexin A2 (Annexin II)IBA 01/2019 - 04/2011
3	Pharmaceutical PreparationsIBA 01/2018 - 02/2015
3	InterferonsIBA 07/2017 - 03/2012
3	Phosphotransferases (Kinase)IBA 12/2015 - 01/2006
3	Lymphotoxin beta ReceptorIBA 05/2007 - 03/2004
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 05/2021 - 07/2017
2	Programmed Cell Death 1 ReceptorIBA 01/2020 - 01/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 01/2020
2	Nonmuscle Myosin Type IIBIBA 01/2019 - 02/2015
2	Nonmuscle Myosin Type IIAIBA 01/2019 - 02/2015
2	Protein Isoforms (Isoforms)IBA 01/2018 - 08/2015
2	Interleukin-17 (Interleukin 17)IBA 01/2018 - 01/2014
2	Complement System Proteins (Complement)IBA 01/2018 - 05/2009
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2017 - 01/2014
2	Messenger RNA (mRNA)IBA 11/2016 - 07/2011
2	CTLA-4 AntigenIBA 01/2016 - 01/2015
2	CurcuminIBA 12/2015 - 09/2011
2	PolyphenolsIBA 12/2015 - 09/2011
2	Semaphorins (Semaphorin)IBA 08/2015 - 03/2003
2	Biological ProductsIBA 03/2013 - 05/2007
2	Neurofibromin 2 (Merlin)IBA 06/2012 - 07/2010
2	Lymphotoxin-alpha (Lymphotoxin)IBA 07/2005 - 06/2005
2	Glycoproteins (Glycoprotein)IBA 07/2005 - 06/2005
2	Caveolin 1IBA 03/2004 - 03/2003
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Granzymes (Granzyme)IBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021
1	atezolizumabIBA 12/2021
1	cobimetinibIBA 12/2021
1	Inhibins (Inhibin)IBA 11/2021
1	Histone Deacetylase InhibitorsIBA 11/2021

Therapy/Procedure

34	Therapeutics 01/2022 - 08/2010
15	Immunotherapy 01/2022 - 01/2013
9	Liver Transplantation 01/2022 - 05/2009
4	Radiotherapy 10/2018 - 01/2016
3	Microspheres (Microsphere) 01/2022 - 10/2018
3	Drug Therapy (Chemotherapy) 01/2020 - 11/2017
3	Castration 01/2018 - 06/2012
3	Transplantation 01/2018 - 03/2007
2	Aftercare (After-Treatment) 11/2016 - 01/2015
1	Molecular Targeted Therapy 01/2022